Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis

NCT05278338 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG: JMT103
DRUG: Denosumab
DRUG: Placebo

Sponsor

Shanghai JMT-Bio Inc.